Reliability and Validity of a New Postoperative Track Assessment Tool (POTraTool)
Reliability and Validity of a New Postoperative Track Assessment Tool - a Prospective Observational Study
연구 개요
상세 설명
The tool includes 2 visual analog scale (VAS) scores estimating indication of an IMC admission and benefit of an IMC stay. The tool was tested in a PACU and in an IMC unit of a Swiss tertiary centre in 2019/2020 (before COVID pandemic). Three raters: one nurse, one physician in charge and the consultant physician, were asked to fill the VAS at the same time for each included patient. The score was done in the 2 first hours following admission in the unit and during the multi professional morning round at day 1.
Reliability was estimated by testing internal consistency (homogeneity), interrater reliability and agreement and test-retest validity (stability). Validity included content validity, construct validity and criterion validity.
연구 유형
등록 (실제)
연락처 및 위치
연구 장소
-
-
-
Geneva, 스위스, 1205
- Geneva University Hospital
-
-
참여기준
자격 기준
공부할 수 있는 나이
건강한 자원 봉사자를 받아들입니다
연구 대상 성별
샘플링 방법
연구 인구
This study was a random sample from the PACU and IMC patients' population. Included patients' variables for demographic description of the population of interest and for the validity testing were: Age in years, gender (male / female), ASA physical score classification (ASA PS), do not resuscitate order (DNR), duration of intervention (min), severity of intervention (minor/intermediate/major), type of surgery (abdominal, orthopedic, trauma and other surgical and non-surgical interventions), elective or non-elective, palliative intervention, SAPS II (admission (2 h after arrival in IMC)), NEMS (admission (2 h after arrival) and during stay in IMC), SAS.
Participating raters were voluntary health care providers working in the peri-interventional unit (PACU and IMC).
설명
Inclusion Criteria:
- PACU patients admitted on Mondays
- IMC patients admitted 7:30am-7:30pm on weekdays
Exclusion Criteria:
- night admission
- PACU patient ASA < 3 or minor intervention
공부 계획
연구는 어떻게 설계됩니까?
디자인 세부사항
연구는 무엇을 측정합니까?
주요 결과 측정
결과 측정 |
측정값 설명 |
기간 |
|---|---|---|
|
Intermediate Care (IMC) indication (VASi)
기간: 2019/2020
|
Health care raters graded the IMC indication (or allocative efficiency) for each patient on a visual analog scale grading from 0 (very low indication of an IMC management) to 100 (very high indication of an IMC management), namely VASi.
|
2019/2020
|
|
Intermediate Care benefit (VASb)
기간: 2019/2020
|
Health care raters graded the IMC benefit (or health gain) for each patient on a visual analog scale grading from 0 (very low benefit from an IMC management) to 100 (very high benefit from an IMC management), namely VASb.
|
2019/2020
|
공동 작업자 및 조사자
수사관
- 연구 책임자: Walder, Professor, University Hospital, Geneva
연구 기록 날짜
연구 주요 날짜
연구 시작 (실제)
기본 완료 (실제)
연구 완료 (실제)
연구 등록 날짜
최초 제출
QC 기준을 충족하는 최초 제출
처음 게시됨 (실제)
연구 기록 업데이트
마지막 업데이트 게시됨 (실제)
QC 기준을 충족하는 마지막 업데이트 제출
마지막으로 확인됨
추가 정보
이 정보는 변경 없이 clinicaltrials.gov 웹사이트에서 직접 가져온 것입니다. 귀하의 연구 세부 정보를 변경, 제거 또는 업데이트하도록 요청하는 경우 register@clinicaltrials.gov. 문의하십시오. 변경 사항이 clinicaltrials.gov에 구현되는 즉시 저희 웹사이트에도 자동으로 업데이트됩니다. .
Po Tra tool에 대한 임상 시험
-
Shenzhen People's Hospital아직 모집하지 않음
-
Necmettin Erbakan UniversityKonya City Hospital모병
-
Priovant Therapeutics, Inc.모집하지 않고 적극적으로포도막염 | 포도막염, 후부 | 포도막염, 중급미국, 스페인, 독일, 이탈리아, 이스라엘, 호주, 아르헨티나, 오스트리아, 벨기에, 체코, 그리스, 헝가리, 영국
-
Norwegian University of Science and TechnologyNorwegian Fund for Postgraduate Training in Physiotherapy완전한
-
PATHBill and Melinda Gates Foundation; UNITAID모병